Crossmark

Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force

Crossref DOI link: https://doi.org/10.14283/jpad.2021.21

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Aisen, P.S.

Bateman, R.J.

Carrillo, M.

Doody, R.

Johnson, K.

Sims, J.R.

Sperling, R.

Vellas, B.
License Information

Text and Data Mining valid from 2021-07-01

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2021-05-24
More Information

This article is maintained by: Elsevier

Article Title: Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2021.21

Content Type: article

Copyright: Copyright © 2021 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS